Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tye

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Biomedical Optics Express|July 18, 2025
Time-resolved Raman spectroscopy using a CMOS SPAD array to remove fluorescent and fibre Raman backgroundsCaitlin S Tye, András Kufcsák, Calum A Ross, et al.
Psychopharmacology|September 1, 1995
Lack of effect of CCKB receptor antagonists in ethological and conditioned animal screens for anxiolytic drugsG R Dawson, N M Rupniak, S D Iversen, et al.
British Journal of Pharmacology|November 1, 1990
The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptorM D Tricklebank, T Honoré, S D Iversen, et al.
Neuropharmacology|March 23, 2000
The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferretsF D Tattersall, W Rycroft, M Cumberbatch, et al.
Journal of Psychopharmacology (Oxford, England)|February 12, 2010
MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humansJ R Atack, K A Wafford, L J Street, et al.
Journal of Psychopharmacology (Oxford, England)|February 17, 2010
Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonistJ R Atack, D J Hallett, S Tye, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Biomedical Optics Express|July 18, 2025
Time-resolved Raman spectroscopy using a CMOS SPAD array to remove fluorescent and fibre Raman backgroundsCaitlin S Tye, András Kufcsák, Calum A Ross, et al.
Psychopharmacology|September 1, 1995
Lack of effect of CCKB receptor antagonists in ethological and conditioned animal screens for anxiolytic drugsG R Dawson, N M Rupniak, S D Iversen, et al.
British Journal of Pharmacology|November 1, 1990
The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptorM D Tricklebank, T Honoré, S D Iversen, et al.
Neuropharmacology|March 23, 2000
The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferretsF D Tattersall, W Rycroft, M Cumberbatch, et al.
Journal of Psychopharmacology (Oxford, England)|February 12, 2010
MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humansJ R Atack, K A Wafford, L J Street, et al.
Journal of Psychopharmacology (Oxford, England)|February 17, 2010
Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonistJ R Atack, D J Hallett, S Tye, et al.
Pageof 2